Revolutionizing drug discovery in lung cancer: An artificial intelligence (AI)-assisted framework for identifying target antigens for antibody-drug conjugates. IJBB [Internet]. 2026 Jan. 20 [cited 2026 May 14];63(2):137-44. Available from: https://or.niscpr.res.in/index.php/IJBB/article/view/22387